Abbisko Therapeutics has raised $235M in total funding. Latest round: IPO. Backed by Temasek, Qiming Venture Partners, Lilly Asia Venture.
Abbisko Therapeutics funding overview
Abbisko Therapeutics has raised $235M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is an IPO announced in October 2021. The round record for Abbisko Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Temasek, Qiming Venture Partners, Lilly Asia Venture. 3 distinct backers are named across the disclosed rounds.
Abbisko Therapeutics at a glance
Total raised
$235M
Latest round
IPO
Latest round date
October 2021
Notable investors
Temasek, Qiming Venture Partners, Lilly Asia Venture
Frequently asked about Abbisko Therapeutics funding
How much has Abbisko Therapeutics raised?
Abbisko Therapeutics has raised $235M in total disclosed funding across the rounds on record.
Who has invested in Abbisko Therapeutics?
Temasek, Qiming Venture Partners, Lilly Asia Venture are named among the investors backing Abbisko Therapeutics.
What was the latest Abbisko Therapeutics funding round?
The most recent disclosed round is an IPO, announced in October 2021.
Where is Abbisko Therapeutics based?
No headquarters location is disclosed for Abbisko Therapeutics.
When did Abbisko Therapeutics last raise?
The last disclosed Abbisko Therapeutics round closed in October 2021 at IPO.
Round data for Abbisko Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
